Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Immune responses associated with protection induced by chemoattenuated PfSPZ vaccine in malaria-naive Europeans
Yoanne D. Mouwenda, Simon P. Jochems, Vincent Van Unen, Madeleine Eunice Betouke Ongwe, Wouter A.A. de Steenhuijsen Piters, Koen A. Stam, Marguerite Massinga Loembe, Betty Kim Lee Sim, Meral Esen, Stephen L. Hoffman, Peter G. Kremsner, Rolf Fendel, Benjamin Mordmüller, Maria Yazdanbakhsh
Yoanne D. Mouwenda, Simon P. Jochems, Vincent Van Unen, Madeleine Eunice Betouke Ongwe, Wouter A.A. de Steenhuijsen Piters, Koen A. Stam, Marguerite Massinga Loembe, Betty Kim Lee Sim, Meral Esen, Stephen L. Hoffman, Peter G. Kremsner, Rolf Fendel, Benjamin Mordmüller, Maria Yazdanbakhsh
View: Text | PDF
Research Article Immunology Vaccines

Immune responses associated with protection induced by chemoattenuated PfSPZ vaccine in malaria-naive Europeans

  • Text
  • PDF
Abstract

Vaccination of malaria-naive volunteers with a high dose of Plasmodium falciparum sporozoites chemoattenuated by chloroquine (CQ) (PfSPZ-CVac [CQ]) has previously demonstrated full protection against controlled human malaria infection (CHMI). However, lower doses of PfSPZ-CVac [CQ] resulted in incomplete protection. This provides the opportunity to understand the immune mechanisms needed for better vaccine-induced protection by comparing individuals who were protected with those not protected. Using mass cytometry, we characterized immune cell composition and responses of malaria-naive European volunteers who received either lower doses of PfSPZ-CVac [CQ], resulting in 50% protection irrespective of the dose, or a placebo vaccination, with everyone becoming infected following CHMI. Clusters of CD4+ and γδ T cells associated with protection were identified, consistent with their known role in malaria immunity. Additionally, EMRA CD8+ T cells and CD56+CD8+ T cell clusters were associated with protection. In a cohort from a malaria-endemic area in Gabon, these CD8+ T cell clusters were also associated with parasitemia control in individuals with lifelong exposure to malaria. Upon stimulation with P. falciparum–infected erythrocytes, CD4+, γδ, and EMRA CD8+ T cells produced IFN-γ and/or TNF, indicating their ability to mediate responses that eliminate malaria parasites.

Authors

Yoanne D. Mouwenda, Simon P. Jochems, Vincent Van Unen, Madeleine Eunice Betouke Ongwe, Wouter A.A. de Steenhuijsen Piters, Koen A. Stam, Marguerite Massinga Loembe, Betty Kim Lee Sim, Meral Esen, Stephen L. Hoffman, Peter G. Kremsner, Rolf Fendel, Benjamin Mordmüller, Maria Yazdanbakhsh

×

Figure 4

Characterization of CD8+ T cells in naturally acquired immunity.

Options: View larger image (or click on image) Download as PowerPoint
Characterization of CD8+ T cells in naturally acquired immunity.
(A) HSN...
(A) HSNE plots showing cell subsets within the CD8+ T cells lineage (left), annotated based on the indicated markers (right). Colors represent the arc-hyperbolic sine 5–transformed (arsinh-5–transformed) marker expression as indicated. (B) Heatmap of CD8+ T cell clusters, showing expression of markers as median signal intensity after arsinh transformation. Each cluster has a unique cluster number, and the subset to which each cluster belongs is shown at the top. The generalized linear mixed models (GLMM) for binomial family was used to compare cluster abundance among malaria-naive Europeans (n = 5, blue), lifelong exposed susceptible Africans (n = 12, green), and resistant Africans (n = 8, pink). Colored stars below the clusters indicate statistical significance in naive Europeans and lifelong exposed resistant Africans. (C and D) Box plot representing the median and first and third quantile of the frequency of (C) EMRA CD8+ T cells (cluster 16) and (D) CD56+CD8+ T cells (cluster 6), both relative to CD45+ cells. The whiskers of the box plots indicate a range no further than 1.5 times the interquartile range (IQR). *P ≤ 0.05, **P < 0.01, ***P < 0.001. P values were computed using the generalized linear mixed models (GLMM) for binomial family.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts